Near-infrared light is used to produce precise photographs of biological tissues in the rapidly developing Near Infrared Imaging Market. Technological advances, medical diagnostic applications, and non-invasive imaging technologies drive this sector's market.
Technological advances drive near-infrared imaging market dynamics. This technique is used more in medical diagnostics and research because of improvements in picture quality, sensitivity, and real-time imaging.
The adaptability of near-infrared imaging in medical diagnostics impacts market dynamics. Many medical professionals employ near-infrared imaging to detect cancer, vascular problems, brain function, and tissue oxygenation.
Near-infrared imaging in cancer diagnosis drives market dynamics. Its real-time tumor vision during surgery aids tumor excision and minimizes tissue damage, making it useful in oncology.
Near-infrared imaging's non-invasiveness drives market dynamics. The method permits imaging underneath living tissues without radiation or intrusive treatments. This makes non-invasive imaging systems popular among healthcare practitioners and patients.
Market dynamics depend on regulatory compliance. Near-infrared imaging systems are safe and effective when medical device rules are followed. Product quality and safety are crucial to market competitiveness and dynamics as companies navigate these regulatory criteria.
Near-infrared imaging system manufacturers and research institutes collaborate to affect market dynamics. Partnerships frequently result in clinical investigations, research, and imaging technology improvements. Research partnerships boost market development and define competition.
Healthcare budgets and affordability affect market dynamics. Near-infrared imaging systems' cost-effectiveness drives product uptake. Healthcare budget limits and economic volatility affect purchase choices, altering market dynamics.
NIR imaging is used due to the growing desire for less invasive surgery. Minimally invasive operations benefit from real-time tissue and vascular imaging without large incisions, affecting market dynamics.
Neurological imaging uses near-infrared imaging, affecting market dynamics. Product development and market preferences are affected by this technology's use in brain function monitoring, cerebral oxygenation assessment, and neurological condition diagnosis.
An important market development is the combination of near-infrared imaging with AI. AI algorithms improve picture processing, interpretation, and diagnosis, making the technology more effective. This integration changes medical diagnostic near-infrared imaging.
The Near infrared imaging market is expected to reach USD 1.1 Billon by 2032 at CAGR 11.5% during the forecast period 2024-2032.
Certain factors increase the market growth. The increasing number of surgical procedures is one of the main causes of the market getting popular. Including this, the rising number of patients with chronic diseases and the increasing geriatric population provide growth for the market. Near-infrared imaging uses light between 650 to 950 nm to detect any changes induced, injury, or disease in the human body. It is a powerful diagnostic tool for a minimally invasive and nonionizing method for tissue imaging.
NIR is not absorbed well by the blood or water, which are the main components of tissues, and so it increases the chances of illumination for internal structures. It is also advantageous over other techniques since it provides better resolution and is less harmless to patients. The increasing number of surgery procedures worldwide for cancer, intestinal and cardiovascular surgeries combined with relevance with target diseases are the factors for the market growth. The growing health awareness in emerging economically high countries will boost the market in the forecast period. Although, the high cost of the infrared detectors and the availability of other alternative techniques will hamper the market growth.
Abbott announced the launch of its new vascular imaging platform in India in October 2023, which is powered by Ultreon 1.0 Software. The intra-vascular imaging software integrates the capabilities of artificial intelligence (AI) with optical coherence tomography (OCT) to offer clinicians a comprehensive understanding of blood flow and blockages within coronary arteries. Detecting the severity of calcium-based blockages, measuring vessel diameter, and distinguishing between calcified and non-calcified blockages are all automated capabilities of the cutting-edge imaging software.
Furthermore, it assists physicians in the precise deployment of stents, the optimization of stent expansion and apposition, and the immediate display of results to improve precision during coronary stenting procedures. The company is utilizing OCT technology to assist physicians in making more informed treatment decisions for their patients with the launch. Recent data indicates that physicians modified their treatment strategy in 88% of coronary artery blockages in response to new information provided by OCT when used in conjunction with MLD MAX, a new workflow that assists physicians in making stent placement decisions and provides them with treatment strategies to optimize that process.
Nikon Corporation (Nikon) has announced the release of the AX R MP with NSPARC super-resolution multiphoton confocal microscope in July 2023. This microscope is capable of achieving super-resolution in deep areas within large living organism specimens and is extremely sensitive to array detection. This product will enhance comprehension of brain diseases, including Alzheimer's and Parkinson's disease, as well as drug discovery research.
Furthermore, Nikon introduced the AX R MP multiphoton confocal microscope last year, which generates high-resolution, high-speed, and expansive field-of-view images in the deepest regions of living organisms. Super-resolution observation of deep areas within living organisms can now be achieved by combining the optical superiority of the AX R MP with the unmatched sensitivity of array-based NSPARC detection. By integrating these technologies, the research on drug discovery in the nervous system will be enhanced, thereby advancing our understanding of diseases like Alzheimer's, Parkinson's, and the mechanisms of dementia.
The near infrared imaging market has been segmented into product type, application, and end user.
By product type, the market has been segmented into devices, reagents, and others. Devices segment is further segmented into near-infrared fluorescence imaging systems and near-infrared bioluminescence imaging systems.
Based on application, the market has been segmented into cancer surgeries, preclinical imaging, reconstructive/plastic surgeries, gastrointestinal surgeries, cardiovascular surgeries, and others.
The near infrared imaging market, by end user, has been segmented into pharmaceutical & biotechnology companies, hospitals & clinics, research laboratories & academic institutions, and others.
The near infrared imaging market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European near infrared imaging market has been segmented into Western Europe and Eastern Europe. The Western Europe market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the near infrared imaging market owing to the high domestic income, and presence of major market players. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion.
Europe is expected to hold the second largest position in the near infrared imaging market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).
The near infrared imaging market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.
The Middle East & Africa has the lowest share of the near infrared imaging market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Market of Near Infrared Imaging, by Key Players
Recent Development
May 2022
A team of scientists whose leader was Professor Hongjie Zhang and Professor Yinghui Wang from State Key Laboratory of Rare Earth Resource Utilisation, Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences, China, Jianhua Liu from the Department of Radiology, The Second Hospital of Jilin University, China, and co-workers have developed a core-shell structured nano theranostics agent (YVO4:Nd3+-HMME@MnO2-LF, marked as YHM) with YVO4:Nd3+ particles as the core and MnO2 nanosheets as the shell.
April 2022
A group of scientists from the Indian Institute of Technology Jodhpur has established that eye images acquired by low-cost near-infrared (NIR) cameras can aid in low design costs. It also provides ease of use and practical solutions for cataract detection. Known as MTCD, the proposed multi task deep learning algorithm is inexpensive and results in very high levels of accuracy.
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)